spacer
home > epc > autumn 2008 > bridging the clinical knowledge gap
PUBLICATIONS
European Pharmaceutical Contractor

Bridging the Clinical Knowledge Gap

We all know that staff involved in clinical research must be appropriately trained – after all it is a mandatory requirement under the GCP guidelines. However, how many staff within clinical study teams are really appropriately trained to work in their therapeutic area which is their field of research specialisation? How many are confident: that they have the background understanding to ensure that protocol requirements are met; that selection criteria are being properly implemented; and that the data collected are consistent? How many understand the significance of adverse events in the context of the disease, its treatment and the therapeutic profile of study drug(s)? Not many.

Recently a colleague bemoaned the fact that some well qualified monitors – medical doctors, in this case – were so focused on the ‘tick box mentality’, rather than the significance of data, that they failed to query a potassium level of 16. The patient would have been dead. From a different point of view, how many study team leaders are confident that their staff can inform and motivate investigators, have balanced discussions on the study and its clinical context, while running the clinical programme effectively with a strong therapy knowledge base? Even fewer, I would suggest.

THE BACKGROUND

Interestingly, the pharmaceutical industry spends vast amounts of money seeking to convince the prescribing fraternity that their drug development programmes, products, services and scientific staff are of the highest calibre, are reliable and ethical. Relative to this, the investment in ensuring that clinical research staff are appropriately educated and informed in their disease area of investigation is woefully small. Why is this the case?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jane Nathan is a Director of PharmaEd and PharmaEd Interactive. Jane’s background combines education and clinical research; both disciplines are combined in the medical education and multimedia functions of PharmaEd. Jane taught in higher education for five years in Biological and Health Sciences at the Polytechnics of Brighton and Central London. Thereafter she moved into clinical research at Glaxo and worked in a variety of therapy areas, in all clinical phases. Jane has worked in medical education for 14 years, and now heads PharmaEd, a specialist medical education agency.
spacer
Jane Nathan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Streamlining patient recruitment using EHR data

The field of (bio)pharmaceutical research is booming. Increasingly more innovative therapeutics are being developed with the ability to drastically improve the quality of life of millions of patients around the world. Rigorously testing each of these candidate drugs for their safety and efficacy is an essential part of the development process. As the number of clinical trials steadily increases, the search for patients who present a specific medical profile and are willing to participate intensifies.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement